Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tg Therapeutics
(NQ:
TGTX
)
23.31
-0.63 (-2.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Tg Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
Next >
NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
October 15, 2024
TG THERAPEUTICS INC (NASDAQ:TGTX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via
Chartmill
Why NASDAQ:TGTX qualifies as a high growth stock.
October 15, 2024
Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing?
Via
Chartmill
For those who appreciate growth without the sticker shock, NASDAQ:TGTX is worth considering.
October 09, 2024
NASDAQ:TGTX is showing decent growth, but is still valued reasonably.
Via
Chartmill
Unlocking the Growth Potential of NASDAQ:TGTX.
September 30, 2024
TG THERAPEUTICS INC (NASDAQ:TGTX) may be suited for growth investing, we'll explore why in this article.
Via
Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via
Benzinga
Stock Market Hits Record Highs On Big Fed Rate Cut; Apple, Intel, FedEx In Focus: Weekly Review
September 20, 2024
TheApple iPhone 16 went on sale amid mixed signals about demand.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Evaluating TG Therapeutics: Insights From 4 Financial Analysts
September 18, 2024
Via
Benzinga
What's Going On With TG Therapeutics Stock Wednesday?
September 18, 2024
TG Therapeutics announced it updated its data presentations to include details from the ULTIMATE I & II Phase 3 trials.
Via
Benzinga
Why NASDAQ:TGTX is Poised for High Growth.
September 09, 2024
Exploring TG THERAPEUTICS INC (NASDAQ:TGTX)'s growth characteristics.
Via
Chartmill
IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug
September 18, 2024
The company unveiled five-year test results for its multiple sclerosis drug, Briumvi.
Via
Investor's Business Daily
Despite its growth, NASDAQ:TGTX remains within the realm of affordability.
September 18, 2024
While growth is established for TG THERAPEUTICS INC (NASDAQ:TGTX), the stock's valuation remains reasonable.
Via
Chartmill
NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
September 16, 2024
TG THERAPEUTICS INC (NASDAQ:TGTX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via
Chartmill
What's Going On With ADMA Biologics Stock Monday?
September 09, 2024
ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
In the world of growth stocks, NASDAQ:TGTX shines as a value proposition.
August 28, 2024
NASDAQ:TGTX, a growth stock which is not overvalued.
Via
Chartmill
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
Decoding TG Therapeutics's Options Activity: What's the Big Picture?
August 19, 2024
Via
Benzinga
IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter
August 19, 2024
The company reported a surprise profit in the second quarter, vs. expectations for losses.
Via
Investor's Business Daily
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
August 19, 2024
Via
Benzinga
Why the growth investor may take a look at NASDAQ:TGTX.
August 19, 2024
Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for growth investing?
Via
Chartmill
A Closer Look at TG Therapeutics's Options Market Dynamics
August 16, 2024
Via
Benzinga
NASDAQ:TGTX: a strong growth stock preparing for the next leg up?.
August 13, 2024
TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock and is consolidating.
Via
Chartmill
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review
August 09, 2024
After Monday's panicked global sell-off, markets have calmed down.
Via
Investor's Business Daily
NASDAQ:TGTX is showing decent growth, but is still valued reasonably.
August 07, 2024
NASDAQ:TGTX stands out as a growth opportunity that won't break the bank.
Via
Chartmill
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates
August 06, 2024
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings
August 06, 2024
Via
Benzinga
Exposures
Fossil Fuels
TGTX Stock Earnings: TG Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
TGTX stock results show that TG Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
August 06, 2024
Via
Benzinga
$1000 Invested In TG Therapeutics 5 Years Ago Would Be Worth This Much Today
July 12, 2024
Via
Benzinga
TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157%
August 06, 2024
The company unexpectedly reported profit in the second quarter, handily beating views for a per-share loss.
Via
Investor's Business Daily
In the world of growth stocks, NASDAQ:TGTX shines as a value proposition.
July 11, 2024
Looking for growth without the hefty price tag? Consider TG THERAPEUTICS INC (NASDAQ:TGTX).
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.